Publications
October 19, 2021

In Depth Assessment of Off-target Editing by CRISPR/Cas9 in VOR33, an Engineered Hematopoietic Stem Cell Transplant for the Treatment of Acute Myeloid Leukemia

Platform, Trem-cel
Presented by: Genome Engineering Team – Vor Bio

ESGCT – 2021 – Poster Presentation P112